AnaptysBio, Inc. ANAB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$84.63M+36.2% | -$132.59M+5.7% | -$140.62M+3.2% | ||
| $543K-2.9% | $559K-2.4% | $573K-0.7% | $577K-2.0% | $589K-2.8% | ||
| $41.12M+14.0% | $36.07M+0.9% | $35.75M+2.8% | $34.78M+5.1% | $33.09M-2.8% | ||
| —— | —— | —— | —— | —— | ||
| -$81.11M+7.1% | -$87.33M+16.8% | -$104.96M-26.4% | -$83.04M-57.6% | -$52.7M-55.7% | ||
| —— | —— | —— | -$2.65M+50.0% | -$5.3M-65.4% | ||
| —— | —— | $6.42M-52.5% | $13.52M-22.1% | $17.35M-48.8% | ||
| $3.08M-35.0% | $4.73M-29.3% | $6.7M-17.7% | $8.13M-9.8% | $9.01M-12.6% | ||
| $1.88M+1.1% | $1.86M+1.0% | $1.85M+1.0% | $1.83M+1.0% | $1.81M+1.0% | ||
| -$1.96M-1.9% | -$1.93M-2.0% | -$1.89M-2.1% | -$1.85M-2.0% | -$1.81M-2.0% | ||
| $4.48M-77.3% | $19.7M+114% | -$144.97M-13.5% | -$127.71M-17.4% | -$108.78M+19.6% | ||
| $69K-20.7% | $87K-75.1% | $349K-6.2% | $372K+1.6% | $366K+2.2% | ||
| $73.86M-62.4% | $196.41M-38.1% | $317.29M-9.1% | $348.98M-21.4% | $443.93M+16.7% | ||
| $322.1M-24.1% | $424.53M-4.1% | $442.78M+3.0% | $429.83M-11.5% | $485.92M+2.1% | ||
| $248.17M+8.8% | $228.03M— | —— | —— | —— | ||
| $64.2M-6.4% | $68.63M+4.5% | $65.7M+17.4% | $55.98M+1,047% | $4.88M+970% | ||
| $27.99M+96.3% | $14.26M+448% | $2.6M-59.3% | $6.4M+7.5% | $5.95M-8.0% | ||
| —— | —— | —— | —— | —— | ||
| -$102.81M+22.5% | -$132.61M-114% | -$61.91M-414% | $19.71M-82.4% | $112.1M-11.8% | ||
| $149.83M+30.2% | $115.12M— | —— | —— | —— | ||
| $82.73M+3.4% | $79.99M-19.2% | $99.06M+26.9% | $78.04M+29.6% | $60.23M+43.0% | ||
| —— | —— | —— | —— | $10.8M-68.2% | ||
| —— | —— | —— | —— | —— | ||
| -$1.96M-1.9% | -$1.93M-2.0% | -$1.89M-2.1% | -$1.85M-2.0% | -$1.81M-2.0% | ||
| —— | —— | —— | -$2.65M+50.0% | -$5.3M-65.4% | ||
| —— | —— | —— | —— | $55.63M+11.1% | ||
| $1.88M+1.1% | $1.86M+1.0% | $1.85M+1.0% | $1.83M+1.0% | $1.81M+1.0% | ||
| $322.1M-24.1% | $424.53M-4.1% | $442.78M+3.0% | $429.83M-11.5% | $485.92M+2.1% | ||
| —— | $0-100% | $25.75K-50.0% | $51.5K-33.3% | $77.25K-25.0% | ||
| $66.6M-13.3% | $76.8M— | —— | —— | —— | ||
| —— | —— | —— | —— | $18K+157% | ||
| -$1.96M-1.9% | -$1.93M-2.0% | -$1.89M-2.1% | -$1.85M-2.0% | -$1.81M-2.0% | ||
| $3.08M-35.0% | $4.73M-29.3% | $6.7M-17.7% | $8.13M-9.8% | $9.01M-12.6% | ||
| —— | —— | —— | —— | $5K— | ||
| —— | —— | $452K+1,659% | -$29K— | $0— | ||
| —— | —— | —— | —— | $959K— | ||
| $4.41M-77.5% | $19.61M+113% | -$145.32M-13.5% | -$128.08M-17.3% | -$109.15M+19.6% | ||
| $4.41M-77.5% | $19.61M+113% | -$145.32M-13.5% | -$128.08M-17.3% | -$109.15M+19.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AnaptysBio, Inc. generate?
- AnaptysBio, Inc. (ANAB) generated $4.5M in operating cash flow over the trailing twelve months.
- What is AnaptysBio, Inc.'s free cash flow?
- After $69.0K of capital expenditures, AnaptysBio, Inc.'s free cash flow was $4.4M over the trailing twelve months, up 104.0% year over year.
- Where does AnaptysBio, Inc.'s cash flow data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
